Endobronchial Obstruction by an Inflammatory Myofibroblastic Tumor

Authors

  • Bruno Silva Pulmonology Department. Unidade Local de Saúde de Santo António. Porto. & Instituto de Ciências Biomédicas Salazar. Universidade do Porto. Porto.
  • Maria Luísa Sacramento Pathology Department. Unidade Local de Saúde de São João. Porto.
  • Hélder Novais e Bastos Pulmonology Department. Unidade Local de Saúde de São João. Porto. & Faculdade de Medicina. Universidade do Porto. Porto. & Instituto de Biologia Molecular e Celular. Instituto de Investigação e Inovação em Saúde (IBMC/i3S). Universidade do Porto. Porto.

DOI:

https://doi.org/10.20344/amp.21664

Keywords:

Airway Obstruction, Bronchial Neoplasms, Bronchoscopy, Myofibroblasts

Abstract

N/a.

Downloads

Download data is not yet available.

References

World Health Organization Classification of tumours editorial board. Thoracic tumours. 5th ed. Lyon: WHO; 2021.

Domínguez-Massa C, Doñate-Bertolín L, Blanco-Herrera OR, Heredia-Cambra T, Pérez-Guillén M, Martínez-Cózar V, et al. Inflammatory myofibroblastic tumor: a rare entity with a complex diagnosis. Rev Port Cardiol. 2023;42:169. DOI: https://doi.org/10.1016/j.repc.2022.12.007

Iyer A, Radonic T, Heukamp LC, Thunnissen E, Daniels JM. Inflammatory myofibroblastic tumour of the central airways: treatment and molecular analysis. ERJ Open Res 2021;7:151-2020. DOI: https://doi.org/10.1183/23120541.00151-2020

Govindaraj V, Gochhait D, Kumar BN, Narayanasami S. Endobronchial inflammatory myofibroblastic tumour- a case report. J Clin Diagn Res. 2016;10:7. DOI: https://doi.org/10.7860/JCDR/2016/20776.8270

Durham C, Clemons M, Alias A, Konduri K. Locally advanced inflammatory myofibroblastic tumor treated with targeted therapy: a case report and literature review. Cureus. 2022;14:e27223. DOI: https://doi.org/10.7759/cureus.27223

Downloads

Published

2024-07-24

How to Cite

1.
Silva B, Sacramento ML, Novais e Bastos H. Endobronchial Obstruction by an Inflammatory Myofibroblastic Tumor. Acta Med Port [Internet]. 2024 Jul. 24 [cited 2024 Nov. 21];37(9):664-5. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/21664

Issue

Vol. 37 No. 9 (2024): September

Section

Letters to the Editor

License

Copyright (c) 2024 Acta Médica Portuguesa

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.

Crossref
Scopus
Google Scholar
Europe PMC